Home Cardiac (non-arrest) Overdrive pacing for refractory pVT prehospital
Cardiac (non-arrest)
Overdrive pacing for refractory pVT prehospital
Transcutaneous overdrive pacing for refractory polymorphic ventricular tachycardia in the prehospital setting: A case report and practical considerations
Emergency Medical Service · Added 27 October 2026
A prehospital case report describes transcutaneous overdrive pacing used as rescue therapy for refractory polymorphic ventricular tachycardia after cardiac arrest, highlighting the gap between guideline options and what ambulances actually carry.
- Study type
- Case series
- Design
- Case report
- Participants
- 1 patient
- Main finding
- Transcutaneous overdrive pacing was implemented prehospital as rescue for recurrent polymorphic VT after OHCA when transvenous pacing was unavailable
- Caveat
- Single case with no comparison or outcome detail beyond the index event
- Bottom line
- Context only
Why it matters in Australia (Medium relevance). Transcutaneous pacing is an intensive care paramedic skill on Australian trucks, and this is a practical rescue option when drugs and shocks fail — but it rests on a single case.
Learning goal
Strengthen my judgement on when transcutaneous overdrive pacing is appropriate rescue therapy for refractory polymorphic ventricular tachycardia.
More
- Topic: Cardiac (non-arrest)
- Daily scan: 27 October 2026
Related papers on Cardiac (non-arrest)
-
Who doesn't call an ambulance for chest pain
Systematic review of 14 Australian studies testing whether equity-related factors affect EMS use for acute coronary syndrome — EMS use ranged 36–79%, with under-49s up to 68% lower odds of calling than over-65s, men 11% lower than women, overseas-born 15% lower, non-English speakers 6–20% lower and remote residents 25% lower than city dwellers.
-
POC troponin on ambulances: fewer ED visits
A French economic model built on 737 patients found prehospital point-of-care high-sensitivity troponin reduced ED attendance (90.9% vs 96.7%) and ED length of stay (1.63 vs 2.76 hours) versus standard care for suspected acute coronary syndrome.
-
Prehospital ACS risk stratification: the evidence
A narrative review of prehospital ACS risk stratification found HEART-derived pathways combined with point-of-care troponin carry the strongest evidence for safe field risk assessment, while AI-assisted ECG interpretation remains promising but prospectively unvalidated.
-
Self-presenting STEMI patients fare worse
Tehran cohort of STEMI patients found those who self-presented had 2.17 times the in-hospital mortality of EMS-transferred patients, alongside longer door-to-balloon times (60 vs 49 minutes).